companydata.dkPFIZER ApS: Financial statements 2024
CVR: 66351912
PFIZER ApS (CVR 66351912) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 847,478,000 and a net result of DKK 13,103,000 compared with DKK 43,535,000 the year before. That is a decrease of 12.2% compared with the year before. The profit margin was 1.5%. Equity amounted to DKK 368,095,000. The solvency ratio was 57.7%. The company had 105 employees in the financial year.
- Revenue
- 847,478,000 kr.
- Gross Profit
- 187,321,000 kr.
- Profit/Loss
- 13,103,000 kr.
- Equity
- 368,095,000 kr.
- Total Assets
- 637,878,000 kr.
- Employees
- 105
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 847.5 mio. | 187.3 mio. | 13.1 mio. | 368.1 mio. | 105 |
| 2023 | 965 mio. | 238.9 mio. | 43.5 mio. | 344.6 mio. | 116 |
| 2022 | 2.3 mia. | 243.1 mio. | 92 mio. | 395.1 mio. | 119 |
| 2021 | 1.6 mia. | 256.2 mio. | 106.1 mio. | 483 mio. | 119 |
| 2020 | 319.9 mio. | 125.1 mio. | 29 mio. | 302.2 mio. | 107 |
How creditworthy is PFIZER ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
PFIZER ApS has won the tender "Rammeaftale om køb af Elrexfio (elranatamab)" issued by Amgros I/S worth 240,000,000 DKK.
PFIZER ApS has won the tender "Lot No. 1" issued by Amgros I/S worth 18,750,000 EUR.
PFIZER ApS has published its annual report for 2023. Revenue came to DKK 964,993,000, and the net result was DKK 43,535,000.
As of February 21, 2024, Anne Bloch Thomsen has joined the board of directors of PFIZER ApS.
As of February 21, 2024, Adam Preben Guhle has left the board of directors of PFIZER ApS.
As of February 20, 2024, Anne Bloch Thomsen has left the board of directors of PFIZER ApS.
About PFIZER ApS
PFIZER ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 1956. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Kjetil Hagen. The company is owned by Pfizer Health AB. The company has 148 employees. In 2025, the company reported revenue of DKK 683,240,000 and a net result of DKK 13,956,000 compared with DKK 13,103,000 the year before. Equity amounted to DKK 315,053,000.